Concentrations were expressed as nM and then recalculated to M in plasma
Conclusion and Future Perspectives In conclusion, vitamin B12 intake may lessen motor symptoms in these patients, improving their physical and mental well-being
Protocol 2: Intermediate approach (experienced researchers) Goal: Multi-target immune modulation with anti-inflammatory support Components: Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly KPV: 200-500 mcg subcutaneously, once daily BPC-157: 250 mcg subcutaneously, twice daily Selank: 250-500 mcg intranasally, once daily Schedule: Monday, Wednesday, Friday: Thymosin alpha-1 Daily AM: KPV + BPC-157 Daily PM: BPC-157 Daily: Selank nasal spray (morning or midday) Duration: 12 weeks on, 4 weeks off Monitoring: Baseline labs, repeat every 4 weeks
No, BPC-157 is not safe despite its claimed benefits
Avoid combining in the same application with strong acids (high-concentration AHA or BHA) because pH extremes can destabilize the copper complex
SAMPLE INFORMED CONSENT Modulation of Intensive Melphalan (L-PAM) By Buthionine Sulfoximine (BSO) With Autologous Stem Cell Support for Resistant/Recurrent High-Risk Neuroblastoma NANT (99-02) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol
